These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9519749)

  • 1. Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
    Giustina A; Perini P; Desenzani P; Bossoni S; Ianniello P; Milani M; Davì G; Romanelli G
    Diabetes; 1998 Mar; 47(3):423-30. PubMed ID: 9519749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term administration of picotamide on baseline and exercise-induced urinary albumin excretion in patients with type II diabetes mellitus and incipient nephropathy.
    Giustina A; Ianniello P; Bossoni S; Comini MT; Desenzani P; Gazzoli N; Romanelli G
    Clin Ther; 1994; 16(2):191-9. PubMed ID: 8062315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM.
    Giustina A; Bossoni S; Cimino A; Comini MT; Gazzoli N; Leproux GB; Wehrenberg WB; Romanelli G; Giustina G
    Diabetes; 1993 Jan; 42(1):178-82. PubMed ID: 8420815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial.
    Cocozza M; Milani M; Picano T; Oliviero U; Russo N; Coto V
    Vasc Med; 1997 Nov; 2(4):292-5. PubMed ID: 9575601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution. A two-year, double-blind, placebo-controlled study in diabetic patients.
    Cocozza M; Picano T; Oliviero U; Russo N; Coto V; Milani M
    Stroke; 1995 Apr; 26(4):597-601. PubMed ID: 7709404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of picotamide, a dual-action antithromboxane agent, in diabetic patients with carotid atherosclerosis: a 6-year follow-up study.
    Coto V; Oliviero U; Cocozza M; Milani M
    J Int Med Res; 1998; 26(4):200-5. PubMed ID: 9818786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of picotamide in the reduction of cardiovascular events in diabetic patients.
    Celestini A; Violi F
    Vasc Health Risk Manag; 2007; 3(1):93-8. PubMed ID: 17583179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG; Coccheri S; Marubini E; Violi F;
    Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
    Milani M; Longoni A; Maderna M
    Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
    Ito S; Shikata K; Nangaku M; Okuda Y; Sawanobori T
    Clin J Am Soc Nephrol; 2019 Aug; 14(8):1161-1172. PubMed ID: 31248950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Picotamide: prevention and therapy of diabetic vasculopathies. A double-blind clinical study].
    Pibiri L; Petruzzo P; De Giudici A; Brotzu G
    Clin Ter; 1990 May; 133(4):233-7. PubMed ID: 2142911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
    Zandbergen AA; Baggen MG; Lamberts SW; Bootsma AH; de Zeeuw D; Ouwendijk RJ
    Ann Intern Med; 2003 Jul; 139(2):90-6. PubMed ID: 12859158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of picotamide, a dual anti-thromboxane agent, in patients with thrombocytosis and a previous thromboembolic event: a 1-year observational study.
    Pogliani E; Milani M
    J Int Med Res; 1996; 24(3):311-5. PubMed ID: 8725994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
    Romanelli G; Giustina A; Bossoni S; Caldonazzo A; Cimino A; Cravarezza P; Giustina G
    Diabetes; 1990 Nov; 39(11):1333-8. PubMed ID: 2227107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease.
    Saitta A; Sardo A; Bonaiuto M; Giordano G; Imbalzano E; Castaldo M; Cinquegrani M; D'Arrigo D; Campo GM; Squadrito F
    Angiology; 1998 Nov; 49(11):879-84. PubMed ID: 9822043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study.
    Sano T; Hotta N; Kawamura T; Matsumae H; Chaya S; Sasaki H; Nakayama M; Hara T; Matsuo S; Sakamoto N
    Diabet Med; 1996 Feb; 13(2):120-4. PubMed ID: 8641115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.